Designated as the research target of TEPIK(Transgovernmental Enterprise for Pandemic Influenza in Korea)
IL-YANG Pharmaceutical developed the innovative antiviral substance and is proceeding with new drug development amid the heightened fear of virus such as the new swine flu and H7N9 bird flu in China. The antiviral substance, developed by IL-YANG Pharmaceutical, has entirely different mechanism of action compared to Tamiflu, the anti-viral agent, and was found in animal experiments to have better efficacy than Tamiflu. Particularly, this antiviral substance was found to have a very excellent effect on Tamiflu resistant virus, which paves the way for the advancement of domestic pharmaceutical technology and acquisition of anti-viral agent sovereignty from the standpoint of national security. This antiviral substance(IY7640) developed by IL-YANG Pharmaceutical was obtained quickly through the high-throughput screening system, and was found to have a wide range of antiviral effect on most influenza virus infecting the human body.
In addition, the group of mice administered with IL-YANG Pharmaceutical’s new antiviral agent(IY7640) showed a survival rate of more than 80% which proves the very excellent antiviral effect on the resistant virus, while the group of mice administered with the conventional Tamiflu died completely.
Along with that, IL-YANG Pharmaceutical’s ‘IY7640‘ was designated as the research target of the “Transgovernmental Enterprise for Pandemic Influenza in Korea (TEPIK/President: Professor Kim Woo-joo)” led by the government. As a result, the new drug development will be pushed forward at a transgovernmental level with the research grant of government. It has been successfully proven to the government officials that this new anti-viral substance has excellent efficacy and totally different mechanism of action than the existing agents made from shikimic acid and provides strong antiviral effect even on Tamiflu resistant virus, and furthermore, the technology incorporated into this innovative anti-viral substance has been well-recognized by the evaluation committee.